Exact Sciences
EXAS
#1718
Rank
NZ$16.81 B
Marketcap
$90.85
Share price
0.70%
Change (1 day)
-15.56%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -NZ$0.26 Billion

According to Exact Sciences's latest financial reports the company's current earnings are NZ$2.61 Billion. In 2023 the company made an earning of -NZ$0.32 Billion, an increase over its 2022 earnings that were of -NZ$1.06 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.26 Billion-19.73%
2023 -NZ$0.32 Billion-69.98%
2022 -NZ$1.06 Billion-25.55%
2021 -NZ$1.43 Billion1.68%
2020 -NZ$1.4 Billion271.17%
2019 -NZ$0.38 Billion58.99%
2018 -NZ$0.24 Billion20.89%
2017 -NZ$0.2 Billion-30.95%
2016 -NZ$0.29 Billion5.09%
2015 -NZ$0.27 Billion57.24%
2014 -NZ$0.18 Billion116.53%
2013 -NZ$79.26 Million
2011 -NZ$49.35 Million143.73%
2010 -NZ$20.25 Million27.85%
2009 -NZ$15.84 Million0.27%
2008 -NZ$15.8 Million-20.95%
2007 -NZ$19.98 Million-13.53%
2006 -NZ$23.11 Million-10.07%
2005 -NZ$25.7 Million-21.81%
2004 -NZ$32.86 Million-33.44%
2003 -NZ$49.37 Million-6.51%
2002 -NZ$52.81 Million17.95%
2001 -NZ$44.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.27 Billion-0.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.11 B-142.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$93.79 Million-64.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$59.87 Million-77.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.68 B-4,883.42%๐Ÿ‡ซ๐Ÿ‡ท France